Table 2 Estimated Japanese disability weights (95% uncertainty interval), compared to the GBD 2013 disability weights

1

Infectious disease, acute episode, mild

0.012 (0.005–0.022)

0.006 (0.002–0.012)

2

Infectious disease, acute episode, moderate

0.424 (0.289–0.577)

0.051 (0.032–0.074)

Japan > GBD

Japan > GBD

3

Infectious disease, acute episode, severe

0.242 (0.163–0.340)

0.133 (0.088–0.190)

4

Infectious disease, post-acute consequences (fatigue, emotional lability, insomnia)

0.074 (0.047–0.106)

0.219 (0.148–0.308)

Japan < GBD

5

Diarrhea, mild

0.119 (0.079–0.165)

0.074 (0.049–0.104)

6

Diarrhea, moderate

0.250 (0.170–0.345)

0.188 (0.125–0.264)

7

Diarrhea, severe

0.387 (0.263–0.517)

0.247 (0.164–0.348)

8

Epididymo-orchitis

0.204 (0.139–0.283)

0.128 (0.086–0.180)

9

Herpes zoster

0.181 (0.123–0.257)

0.058 (0.035–0.090)

Japan > GBD

Japan > GBD

10

HIV cases, symptomatic, pre-AIDS

0.200 (0.140–0.275)

0.274 (0.184–0.377)

11

HIV/AIDS cases, receiving ARV treatment

0.155 (0.108–0.219)

0.078 (0.052–0.111)

12

AIDS cases, not receiving ARV treatment

0.394 (0.268–0.527)

0.582 (0.406–0.743)

13

Ear pain

0.058 (0.037–0.085)

0.013 (0.007–0.024)

Japan > GBD

Japan > GBD

14

Tuberculosis, HIV infected

0.267 (0.181–0.372)

0.408 (0.274–0.549)

15

Tuberculosis, not HIV infected

0.254 (0.175–0.348)

0.333 (0.224–0.454)

16

Cancer, diagnosis and primary therapy

0.174 (0.121–0.243)

0.288 (0.193–0.399)

17

Cancer, metastatic

0.230 (0.158–0.312)

0.451 (0.307–0.600)

18

Cancer, after treatment

0.079 (0.052–0.115)

NA

19

Mastectomy

0.075 (0.047–0.108)

0.036 (0.020–0.057)

Japan > GBD

20

Stoma

0.146 (0.099–0.200)

0.095 (0.063–0.131)

21

Terminal phase, with medication (for cancers, end-stage kidney/liver disease)

0.589 (0.425–0.743)

0.540 (0.377–0.687)

22

Terminal phase, without medication (for cancers, end-stage kidney/liver disease)

0.537 (0.378–0.693)

0.569 (0.389–0.727)

23

Acute myocardial infarction: days 1-2

0.253 (0.173–0.353)

0.432 (0.288–0.579)

24

Acute myocardial infarction, days 3-28

0.032 (0.019–0.050)

0.074 (0.049–0.105)

Japan < GBD

25

Angina pectoris, mild

0.019 (0.010–0.033)

0.033 (0.020–0.052)

26

Angina pectoris, moderate

0.040 (0.024–0.062)

0.080 (0.052–0.133)

27

Angina pectoris, severe

0.163 (0.111–0.227)

0.167 (0.110–0.240)

28

Cardiac conduction disorders and cardiac dysrhythmias

0.426 (0.297–0.561)

0.224 (0.151–0.312)

29

Claudication

0.020 (0.011–0.034)

0.014 (0.007–0.025)

30

Heart failure, mild

0.016 (0.008–0.028)

0.041 (0.026–0.062)

Japan < GBD

31

Heart failure, moderate

0.041 (0.025–0.061)

0.072 (0.047–0.103)

32

Heart failure, severe

0.240 (0.166–0.336)

0.179 (0.122–0.251)

33

Stroke: long-term consequences, mild

0.019 (0.010–0.033)

0.019 (0.010–0.032)

34

Stroke: long-term consequences, moderate

0.044 (0.027–0.067)

0.070 (0.046–0.099)

35

Stroke: long-term consequences, moderate plus cognition problems

0.108 (0.074–0.150)

0.316 (0.206–0.437)

Japan < GBD

36

Stroke: long-term consequences, severe

0.550 (0.386–0.701)

0.552 (0.377–0.707)

37

Stroke: long-term consequences, severe plus cognition problems

0.579 (0.411–0.732)

0.588 (0.411–0.744)

38

Diabetic foot

0.064 (0.041–0.093)

0.020 (0.010–0.034)

Japan > GBD

Japan > GBD

39

Diabetic neuropathy

0.098 (0.063–0.136)

0.133 (0.089–0.187)

40

Chronic kidney disease (stage IV)

0.106 (0.070–0.151)

0.104 (0.070–0.147)

41

End-stage renal disease, on dialysis

0.278 (0.189–0.382)

0.571 (0.398–0.725)

Japan < GBD

42

End-stage renal disease, with kidney transplant

0.018 (0.010–0.032)

0.024 (0.014–0.039)

43

Decompensated cirrhosis of the liver

0.101 (0.067–0.144)

0.178 (0.123–0.250)

44

Gastric bleeding

0.541 (0.387–0.690)

0.325 (0.209–0.462)

45

Crohn’s disease or ulcerative colitis

0.219 (0.152–0.308)

0.231 (0.156–0.320)

46

Benign prostatic hypertrophy: symptomatic

0.096 (0.064–0.136)

0.067 (0.043–0.097)

47

Urinary incontinence

0.210 (0.143–0.292)

0.139 (0.094–0.198)

48

Stress incontinence

0.014 (0.007–0.026)

0.020 (0.011–0.035)

49

Impotence

0.017 (0.009–0.030)

0.017 (0.009–0.030)

50

Infertility, primary

0.009 (0.004–0.018)

0.008 (0.003–0.015)

51

Infertility, secondary

0.008 (0.003–0.016)

0.005 (0.002–0.011)

52

Asthma, controlled

0.006 (0.003–0.013)

0.015 (0.007–0.026)

Japan < GBD

53

Asthma, partially controlled

0.044 (0.027–0.065)

0.036 (0.022–0.055)

54

Asthma: uncontrolled

0.212 (0.145–0.294)

0.133 (0.086–0.192)

55

COPD and other chronic respiratory problems, mild

0.008 (0.003–0.016)

0.019 (0.007–0.026)

Japan < GBD

56

COPD and other chronic respiratory problems, moderate

0.232 (0.158–0.319)

0.225 (0.153–0.310)

57

COPD and other chronic respiratory problems, severe

0.299 (0.203–0.405)

0.408 (0.273–0.556)

58

Dementia, mild

0.037 (0.022–0.056)

0.069 (0.046–0.099)

59

Dementia, moderate

0.382 (0.263–0.519)

0.377 (0.252–0.508)

60

Dementia, severe

0.511 (0.358–0.657)

0.449 (0.304–0.595)

61

Headache: migraine

0.518 (0.365–0.668)

0.441 (0.294–0.588)

62

Headache: tension-type

0.109 (0.074–0.153)

0.037 (0.022–0.057)

Japan > GBD

63

Headache: medication overuse

0.185 (0.129–0.262)

0.223 (0.146–0.313)

64

Multiple sclerosis, mild

0.235 (0.160–0.324)

0.183 (0.124–0.253)

65

Multiple sclerosis, moderate

0.467 (0.325–0.615)

0.463 (0.313–0.613)

66

Multiple sclerosis, severe

0.653 (0.483–0.798)

0.719 (0.534–0.858)

67

Epilepsy, seizures ≥ once a month

0.533 (0.373–0.686)

0.552 (0.375–0.710)

68

Epilepsy, seizures < once a month

0.396 (0.273–0.525)

0.263 (0.173–0.367)

69

Parkinson’s disease, mild

0.016 (0.008–0.028)

0.010 (0.005–0.019)

70

Parkinson’s disease, moderate

0.193 (0.133–0.269)

0.267 (0.181–0.372)

71

Parkinson’s disease, severe

0.527 (0.372–0.681)

0.575 (0.396–0.730)

72

Alcohol use disorder, very mild

0.064 (0.040–0.092)

0.123 (0.082–0.177)

73

Alcohol use disorder, mild

0.219 (0.151–0.306)

0.235 (0.160–0.327)

74

Alcohol use disorder, moderate

0.312 (0.213–0.422)

0.373 (0.248–0.508)

75

Alcohol use disorder, severe

0.413 (0.282–0.551)

0.570 (0.396–0.732)

76

Drug dependence, mild

0.330 (0.229–0.446)

NA

77

Drug dependence

0.581 (0.419–0.740)

NA

78

Anxiety disorders, mild

0.014 (0.007–0.026)

0.030 (0.018–0.046)

Japan < GBD

79

Anxiety disorders, moderate

0.108 (0.072–0.150)

0.133 (0.091–0.186)

80

Anxiety disorders, severe

0.376 (0.258–0.509)

0.523 (0.362–0.677)

81

Major depressive disorder, mild episode

0.060 (0.038–0.088)

0.145 (0.099–0.209)

Japan < GBD

82

Major depressive disorder, moderate episode

0.302 (0.204–0.410)

0.396 (0.267–0.531)

83

Major depressive disorder, severe episode

0.533 (0.378–0.680)

0.658 (0.477–0.807)

84

Bipolar disorder: manic episode

0.321 (0.220–0.439)

0.492 (0.341–0.646)

85

Bipolar disorder: residual state

0.031 (0.017–0.048)

0.032 (0.018–0.051)

86

Schizophrenia: acute state

0.575 (0.408–0.733)

0.778 (0.606–0.900)

87

Schizophrenia: residual state

0.412 (0.283–0.554)

0.588 (0.411–0.754)

88

Anorexia nervosa

0.196 (0.137–0.272)

0.224 (0.150–0.312)

89

Bulimia nervosa

0.280 (0.191–0.378)

0.223 (0.150–0.312)

90

Attention deficit hyperactivity disorder

0.052 (0.032–0.076)

0.045 (0.028–0.066)

91

Conduct disorder

0.243 (0.167–0.332)

0.241 (0.159–0.341)

92

Asperger’s syndrome

0.099 (0.065–0.142)

0.104 (0.071–0.147)

93

Autism

0.176 (0.122–0.245)

0.262 (0.176–0.365)

94

Intellectual disability, borderline

0.014 (0.006–0.024)

0.011 (0.005–0.020)

95

Intellectual disability, mild

0.047 (0.030–0.071)

0.043 (0.026–0.064)

96

Intellectual disability, moderate

0.074 (0.047–0.108)

0.100 (0.066–0.142)

97

Intellectual disability, severe

0.122 (0.083–0.172)

0.160 (0.107–0.266)

98

Intellectual disability, profound

0.230 (0.159–0.317)

0.200 (0.133–0.283)

99

Hearing loss, mild

0.027 (0.015–0.044)

0.010 (0.004–0.019)

Japan > GBD

100

Hearing loss, moderate

0.038 (0.023–0.057)

0.027 (0.015–0.042)

101

Hearing loss, severe

0.208 (0.143–0.294)

0.158 (0.105–0.227)

102

Hearing loss, profound

0.241 (0.167–0.338)

0.204 (0.134–0.288)

103

Hearing loss, complete

0.300 (0.206–0.409)

0.215 (0.144–0.307)

104

Hearing loss, mild, with ringing

0.047 (0.029–0.069)

0.021 (0.012–0.036)

Japan > GBD

105

Hearing loss, moderate, with ringing

0.119 (0.080–0.166)

0.031 (0.019–0.049)

Japan > GBD

Japan > GBD

106

Hearing loss, severe, with ringing

0.280 (0.193–0.386)

0.261 (0.175–0.360)

107

Hearing loss, profound, with ringing

0.307 (0.214–0.414)

0.277 (0.182–0.387)

108

Hearing loss, complete, with ringing

0.379 (0.266–0.514)

0.316 (0.212–0.435)

109

Distance vision, mild impairment

0.005 (0.002–0.012)

0.003 (0.001–0.007)

110

Distance vision, moderate impairment

0.051 (0.032–0.074)

0.031 (0.019–0.049)

111

Distance vision, severe impairment

0.378 (0.266–0.514)

0.184 (0.124–0.260)

Japan > GBD

112

Distance vision blindness

0.427 (0.299–0.570)

0.187 (0.124–0.260)

Japan > GBD

113

Near vision impairment

0.012 (0.006–0.023)

0.011 (0.005–0.020)

114

Low back pain, mild

0.028 (0.016–0.045)

0.020 (0.011–0.035)

115

Low back pain, moderate

0.069 (0.044–0.100)

0.054 (0.035–0.079)

116

Back pain, severe, without leg pain

0.190 (0.132–0.263)

0.272 (0.182–0.373)

117

Back pain, severe, with leg pain

0.276 (0.190–0.381)

0.325 (0.219–0.446)

118

Back pain, most severe, without leg pain

0.200 (0.141–0.274)

0.367 (0.227–0.523)

119

Back pain, most severe, with leg pain

0.276 (0.186–0.379)

0.379 (0.236–0.540)

120

Neck pain, mild

0.039 (0.023–0.058)

0.053 (0.034–0.078)

121

Neck pain, moderate

0.063 (0.041–0.091)

0.114 (0.075–0.162)

122

Neck pain, severe

0.169 (0.115–0.236)

0.229 (0.153–0.317)

123

Neck pain, most severe

0.144 (0.099–0.200)

0.304 (0.202–0.415)

Japan < GBD

124

Musculoskeletal problems, lower limbs, mild

0.091 (0.060–0.129)

0.023 (0.013–0.037)

Japan > GBD

Japan > GBD

125

Musculoskeletal problems, lower limbs, moderate

0.142 (0.098–0.196)

0.079 (0.054–0.110)

126

Musculoskeletal problems, lower limbs, severe

0.327 (0.223–0.438)

0.165 (0.112–0.232)

127

Musculoskeletal problems, upper limbs, mild

0.039 (0.023–0.058)

0.028 (0.017–0.045)

128

Musculoskeletal problems, upper limbs, moderate

0.223 (0.153–0.307)

0.117 (0.080–0.163)

129

Musculoskeletal problems, generalized, moderate

0.255 (0.177–0.352)

0.317 (0.216–0.440)

130

Musculoskeletal problems, generalized, severe

0.420 (0.293–0.560)

0.581 (0.403–0.739)

131

Grout: Acute

0.322 (0.221–0.436)

0.295 (0.196–0.409)

132

Amputation of finger(s), excluding thumb

0.063 (0.041–0.092)

0.005 (0.002–0.010)

Japan > GBD

Japan > GBD

133

Amputation of thumb (long term)

0.093 (0.061–0.132)

0.011 (0.005–0.021)

Japan > GBD

Japan > GBD

134

Amputation of one upper limb (with treatment)

0.144 (0.096–0.205)

0.039 (0.024–0.059)

Japan > GBD

Japan > GBD

135

Amputation of one upper limb (long term, without treatment)

0.261 (0.182–0.357)

0.118 (0.079–0.167)

Japan > GBD

136

Amputation of both upper limbs (long term, with treatment)

0.193 (0.132–0.274)

0.123 (0.081–0.176)

137

Amputation of both upper limbs (long term, without treatment)

0.422 (0.295–0.562)

0.383 (0.251–0.525)

138

Amputation of toe

0.080 (0.052–0.114)

0.006 (0.002–0.012)

Japan > GBD

Japan > GBD

139

Amputation of one lower limb (long term, with treatment)

0.096 (0.062–0.140)

0.039 (0.023–0.059)

Japan > GBD

140

Amputation of one lower limb (long term, without treatment)

0.233 (0.162–0.318)

0.173 (0.118–0.240)

141

Amputation of both lower limbs (long term, with treatment)

0.146 (0.101–0.203)

0.088 (0.057–0.124)

142

Amputation of both lower limbs (long term, without treatment)

0.525 (0.377–0.681)

0.443 (0.297–0.589)

143

Burns, <20% total burned surface area or < 10% total burned surface area if head/neck or hands/wrist involved (long term, with or without treatment)

0.018 (0.009–0.031)

0.016 (0.008–0.032)

144

Burns, ≥20% total burned surface area (short term, with or without treatment)

0.208 (0.140–0.302)

0.314 (0.211–0.441)

145

Burns, ≥20% total burned surface area or ≥10% total burned surface area if head/neck or hands/wrist involved (long term, with treatment)

0.126 (0.085–0.176)

0.135 (0.092–0.190)

146

Burns, ≥20% total burned surface area or ≥10% total burned surface area if head/neck or hands/wrist involved (long term, without treatment)

0.396 (0.274–0.534)

0.455 (0.302–0.601)

147

Crush injury (short or long term, with or without treatment)

0.185 (0.129–0.257)

0.132 (0.089–0.189)

148

Dislocation of hip (long term, with or without treatment)

0.035 (0.021–0.053)

0.016 (0.008–0.028)

Japan > GBD

149

Dislocation of knee (long term, with or without treatment)

0.252 (0.174–0.347)

0.113 (0.075–0.160)

Japan > GBD

150

Dislocation of shoulder (long term, with or without treatment)

0.132 (0.091–0.187)

0.062 (0.041–0.088)

Japan > GBD

151

Other injuries of muscle and tendon (includes sprains, strains and dislocations other than shoulder, knee, hip)

0.032 (0.018–0.049)

0.008 (0.003–0.015)

Japan > GBD

Japan > GBD

152

Drowning and nonfatal submersion (short or long term, with or without treatment)

0.079 (0.052–0.114)

0.247 (0.164–0.341)

Japan < GBD

Japan < GBD

153

Fracture of clavicle, scapula or humerus (short or long term, with or without treatment)

0.159 (0.106–0.222)

0.035 (0.021–0.053)

Japan > GBD

Japan > GBD

154

Fracture of face bone (short or long term with or without treatment)

0.184 (0.128–0.259)

0.067 (0.044–0.097)

Japan > GBD

155

Fracture of foot bones (short term, with or without treatment)

0.094 (0.062–0.132)

0.026 (0.015–0.043)

Japan > GBD

Japan > GBD

156

Fracture of foot bones (long term, without treatment)

0.045 (0.027–0.066)

0.026 (0.015–0.042)

157

Fracture of hand (short term, with or without treatment)

0.041 (0.025–0.062)

0.010 (0.005–0.019)

Japan > GBD

Japan > GBD

158

Fracture of hand (long term, without treatment)

0.037 (0.022–0.058)

0.014 (0.007–0.025)

Japan > GBD

159

Fracture of neck of femur (short term, with or without treatment)

0.321 (0.218–0.437)

0.258 (0.172–0.356)

160

Fracture of neck of femur (long term, with treatment)

0.120 (0.079–0.168)

0.058 (0.038–0.084)

Japan > GBD

161

Fracture of neck of femur (long term, without treatment)

0.375 (0.260–0.502)

0.402 (0.269–0.541)

162

Fracture, other than femoral neck (short term, with or without treatment)

0.233 (0.159–0.324)

0.111 (0.074–0.156)

Japan > GBD

163

Fracture, other than femoral neck (long term, without treatment)

0.079 (0.052–0.113)

0.042 (0.027–0.063)

164

Fracture of patella, tibia or fibula or ankle (short term, with or without treatment)

0.213 (0.143–0.294)

0.050 (0.032–0.075)

Japan > GBD

Japan > GBD

165

Fracture of patella, tibia or fibula or ankle (long term, with or without treatment)

0.122 (0.083–0.170)

0.055 (0.036–0.081)

Japan > GBD

166

Fracture of pelvis (short term)

0.431 (0.296–0.577)

0.279 (0.188–0.384)

167

Fracture of pelvis (long term)

0.143 (0.098–0.204)

0.182 (0.123–0.253)

168

Fracture of radius or ulna (short term, with or without treatment)

0.081 (0.054–0.118)

0.028 (0.016–0.046)

Japan > GBD

169

Fracture of radius or ulna (long term, without treatment)

0.079 (0.052–0.111)

0.043 (0.028–0.064)

170

Fracture of skull (short or long term, with or without treatment)

0.132 (0.087–0.190)

0.071 (0.048–0.100)

171

Fracture of sternum and/or fracture of one or two ribs (short term, with or without treatment)

0.170 (0.116–0.238)

0.103 (0.068–0.145)

172

Fracture of vertebral column (short or long term, with or without treatment)

0.106 (0.070–0.147)

0.111 (0.075–0.156)

173

Fractures, treated (long term)

0.008 (0.003–0.017)

0.005 (0.002–0.014)

174

Injured nerves (short term)

0.237 (0.157–0.329)

0.100 (0.067–0.140)

Japan > GBD

175

Injured nerves (long term)

0.161 (0.111–0.223)

0.113 (0.076–0.157)

176

Injury to eyes (short term)

0.076 (0.049–0.109)

0.054 (0.035–0.081)

177

Concussion

0.170 (0.112–0.244)

0.110 (0.074–0.158)

178

Severe traumatic brain injury, short term (with or without treatment)

0.114 (0.075–0.162)

0.214 (0.141–0.297)

179

Traumatic brain injury, long-term consequences, minor (with or without treatment)

0.192 (0.132–0.266)

0.094 (0.063–0.133)

Japan > GBD

180

Traumatic brain injury, long-term consequences, moderate (with or without treatment)

0.212 (0.144–0.299)

0.231 (0.156–0.324)

181

Traumatic brain injury, long-term consequences, severe (with or without treatment)

0.455 (0.315–0.600)

0.637 (0.462–0.789)

182

Open wound (short term, with or without treatment)

0.035 (0.021–0.055)

0.006 (0.002–0.012)

Japan > GBD

Japan > GBD

183

Poisoning (short term with or without treatment)

0.276 (0.193–0.377)

0.163 (0.109–0.227)

184

Severe chest injury (long term, with or without treatment)

0.065 (0.042–0.095)

0.047 (0.030–0.070)

185

Severe chest injury (short term, with or without treatment)

0.220 (0.152–0.306)

0.369 (0.248–0.501)

186

Spinal cord lesion below neck level (treated)

0.388 (0.270–0.524)

0.296 (0.198–0.414)

187

Spinal cord lesion below neck level (untreated)

0.564 (0.404–0.722)

0.623 (0.434–0.777)

188

Spinal cord lesion at neck level (treated)

0.637 (0.468–0.792)

0.589 (0.415–0.748)

189

Spinal cord lesion at neck level (untreated)

0.707 (0.527–0.842)

0.732 (0.544–0.871)

190

Abdominopelvic problem, mild

0.029 (0.016–0.046)

0.011 (0.005–0.021)

Japan > GBD

191

Abdominopelvic problem, moderate

0.392 (0.270–0.524)

0.114 (0.078–0.159)

Japan > GBD

Japan > GBD

192

Abdominopelvic problem, severe

0.339 (0.235–0.458)

0.324 (0.220–0.442)

193

Anemia, mild

0.004 (0.001–0.009)

0.004 (0.001–0.008)

194

Anemia, moderate

0.064 (0.040–0.092)

0.052 (0.034–0.076)

195

Anemia, severe

0.040 (0.024–0.061)

0.149 (0.101–0.209)

Japan < GBD

Japan < GBD

196

Periodontitis

0.008 (0.003–0.015)

0.007 (0.003–0.014)

197

Dental caries: symptomatic

0.035 (0.021–0.053)

0.010 (0.005–0.019)

Japan > GBD

Japan > GBD

198

Severe tooth loss

0.082 (0.053–0.115)

0.067 (0.045–0.095)

199

Disfigurement: level 1

0.043 (0.026–0.063)

0.011 (0.005–0.021)

Japan > GBD

Japan > GBD

200

Disfigurement: level 2

0.123 (0.083–0.171)

0.067 (0.044–0.096)

201

Disfigurement: level 3

0.512 (0.362–0.670)

0.405 (0.275–0.546)

202

Generic uncomplicated disease: worry and daily medication

0.016 (0.008–0.028)

0.049 (0.031–0.072)

Japan < GBD

Japan < GBD

203

Generic uncomplicated disease: anxiety about diagnosis

0.008 (0.003–0.015)

0.012 (0.006–0.023)

204

Severe wasting

0.086 (0.056–0.124)

0.128 (0.082–0.183)

205

Speech problems

0.065 (0.041–0.094)

0.051 (0.032–0.078)

206

Motor impairment, mild

0.009 (0.004–0.016)

0.010 (0.005–0.019)

207

Motor impairment, moderate

0.045 (0.028–0.065)

0.061 (0.040–0.089)

208

Motor impairment, severe

0.294 (0.202–0.396)

0.402 (0.268–0.545)

209

Motor plus cognitive impairments, mild

0.023 (0.013–0.038)

0.031 (0.018–0.050)

210

Motor plus cognitive impairments, moderate

0.106 (0.069–0.150)

0.203 (0.134–0.290)

211

Motor plus cognitive impairments, severe

0.457 (0.318–0.606)

0.542 (0.374–0.702)

212

Thrombocytopenic purpura

0.110 (0.073–0.154)

0.159 (0.106–0.226)

213

Hypothyroidism

0.012 (0.005–0.023)

0.019 (0.010–0.032)

214

Hyperthyroidism

0.103 (0.069–0.146)

0.145 (0.096–0.202)

215

Vertigo and balance disorder (Menière, labyrinthitis)

0.102 (0.069–0.145)

0.113 (0.074–0.158)

216

Allergic rhinitis (hay fever)

0.009 (0.004–0.016)

0.007 (0.003–0.017)

217

Borderline personality disorder

0.132 (0.091–0.186)

0.190 (0.120–0.262)

218

Carpal tunnel syndrome

0.020 (0.011–0.034)

0.035 (0.023–0.055)

219

Constipation

0.048 (0.030–0.070)

0.061 (0.040–0.093)

220

Hemorrhoids

0.090 (0.058–0.127)

0.109 (0.072–0.154)

221

Heart burn and reflux “GERD”

0.046 (0.029–0.069)

0.027 (0.015–0.046)

222

Insomnia

0.036 (0.022–0.055)

0.016 (0.009–0.031)

Japan > GBD

223

Intensive care unit admission

0.675 (0.506–0.822)

0.739 (0.526–0.891)

224

Invasive device/drain

0.512 (0.362–0.664)

0.143 (0.095–0.207)

Japan > GBD

Japan > GBD

225

Irritable bowel syndrome

0.039 (0.024–0.059)

0.064 (0.040–0.093)

226

Sleep apnea

0.024 (0.014–0.040)

0.032 (0.020–0.051)

227

Somatoform disorder

0.060 (0.038–0.086)

0.140 (0.095–0.199)

Japan < GBD

228

Varicose veins

0.018 (0.010–0.031)

0.020 (0.010–0.037)

229

Trigeminal neuralgia

0.128 (0.086–0.181)

0.068 (0.045–0.101)

230

Vaginal discharge

0.096 (0.062–0.135)

NA

231

Dermatitis

0.079 (0.050–0.115)

NA